| 注册
首页|期刊导航|肿瘤学创新(英文)|Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers

Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers

Haixia Cheng Yuchen Jiao Mei Liu Lingying Wu Guangwen Yuan Leilei Liang Tiantian Wang Jiarun Zhu Hongying Yang Zhendiao Zhou Pei Wang Qianqian Song

肿瘤学创新(英文)2025,Vol.4Issue(4):25-35,11.
肿瘤学创新(英文)2025,Vol.4Issue(4):25-35,11.DOI:10.1002/cai2.70014

Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers

Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers

Haixia Cheng 1Yuchen Jiao 1Mei Liu 1Lingying Wu 2Guangwen Yuan 2Leilei Liang 2Tiantian Wang 2Jiarun Zhu 1Hongying Yang 3Zhendiao Zhou 1Pei Wang 1Qianqian Song1

作者信息

  • 1. Laboratory of Cell and Molecular Biology&State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
  • 2. Department of Gynecologic Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
  • 3. Peking University Cancer Hospital Yunnan Hospital/Yunnan Provincial Cancer Hospital/The Third Affiliated Hospital of Kunming Medical University,Kunming,Yunnan,China
  • 折叠

摘要

关键词

circulating tumor DNA/copy number alterations/ovarian cancer/TP53 mutations

Key words

circulating tumor DNA/copy number alterations/ovarian cancer/TP53 mutations

引用本文复制引用

Haixia Cheng,Yuchen Jiao,Mei Liu,Lingying Wu,Guangwen Yuan,Leilei Liang,Tiantian Wang,Jiarun Zhu,Hongying Yang,Zhendiao Zhou,Pei Wang,Qianqian Song..Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers[J].肿瘤学创新(英文),2025,4(4):25-35,11.

基金项目

This study was partly supported by the National Key R&D Program of China(Grant No.2016YFC13037040)and the Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences(Grant No.2022-RC310-08). (Grant No.2016YFC13037040)

肿瘤学创新(英文)

2770-9183

访问量1
|
下载量0
段落导航相关论文